Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biocompatible Materials | 12 | 2025 | 125 | 4.720 |
Why?
|
| Tissue Engineering | 10 | 2025 | 166 | 4.100 |
Why?
|
| Collagen | 6 | 2025 | 294 | 3.140 |
Why?
|
| Aptamers, Nucleotide | 3 | 2025 | 35 | 2.050 |
Why?
|
| Tissue Scaffolds | 8 | 2022 | 91 | 1.940 |
Why?
|
| Neovascularization, Physiologic | 4 | 2025 | 198 | 1.730 |
Why?
|
| Hydrogels | 2 | 2025 | 92 | 1.550 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2022 | 441 | 1.540 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2025 | 65 | 1.450 |
Why?
|
| Bone Regeneration | 2 | 2020 | 30 | 1.270 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 7 | 2025 | 93 | 1.080 |
Why?
|
| DNA | 2 | 2025 | 1427 | 1.060 |
Why?
|
| Regenerative Medicine | 2 | 2025 | 35 | 1.010 |
Why?
|
| Nucleic Acids | 1 | 2025 | 23 | 0.950 |
Why?
|
| DNA, Single-Stranded | 2 | 2025 | 69 | 0.850 |
Why?
|
| Stress, Mechanical | 2 | 2021 | 169 | 0.820 |
Why?
|
| Orthopedics | 2 | 2014 | 75 | 0.780 |
Why?
|
| Endothelial Cells | 2 | 2019 | 505 | 0.740 |
Why?
|
| Free Radical Scavengers | 2 | 2019 | 53 | 0.730 |
Why?
|
| Polymers | 3 | 2018 | 105 | 0.710 |
Why?
|
| Aptamers, Peptide | 1 | 2020 | 4 | 0.690 |
Why?
|
| Oligopeptides | 1 | 2020 | 113 | 0.660 |
Why?
|
| Minerals | 1 | 2020 | 59 | 0.650 |
Why?
|
| Magnoliopsida | 1 | 2019 | 5 | 0.640 |
Why?
|
| Materials Testing | 7 | 2019 | 77 | 0.640 |
Why?
|
| Textiles | 1 | 2019 | 12 | 0.630 |
Why?
|
| Citrates | 2 | 2018 | 26 | 0.610 |
Why?
|
| Alloys | 5 | 2018 | 14 | 0.600 |
Why?
|
| Cerium | 2 | 2019 | 5 | 0.590 |
Why?
|
| Elastin | 1 | 2018 | 25 | 0.580 |
Why?
|
| Collagen Type I | 1 | 2018 | 114 | 0.570 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 426 | 0.560 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 226 | 0.520 |
Why?
|
| Ceramics | 2 | 2014 | 13 | 0.520 |
Why?
|
| Cell Line | 5 | 2021 | 2558 | 0.490 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2016 | 11 | 0.480 |
Why?
|
| Weightlessness Simulation | 1 | 2016 | 21 | 0.480 |
Why?
|
| Blood Vessels | 1 | 2016 | 99 | 0.470 |
Why?
|
| Cell Survival | 4 | 2020 | 824 | 0.430 |
Why?
|
| Barium Compounds | 1 | 2013 | 6 | 0.410 |
Why?
|
| Osteoblasts | 4 | 2020 | 160 | 0.410 |
Why?
|
| Titanium | 1 | 2013 | 22 | 0.410 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2019 | 126 | 0.380 |
Why?
|
| Cells, Cultured | 5 | 2021 | 2896 | 0.380 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1848 | 0.370 |
Why?
|
| Acute Chest Syndrome | 1 | 2011 | 10 | 0.360 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2019 | 179 | 0.360 |
Why?
|
| Humans | 25 | 2025 | 125613 | 0.330 |
Why?
|
| Endothelium | 1 | 2010 | 62 | 0.320 |
Why?
|
| Magnesium | 4 | 2018 | 118 | 0.300 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 324 | 0.270 |
Why?
|
| Animals | 8 | 2025 | 33094 | 0.240 |
Why?
|
| Aorta | 2 | 2019 | 503 | 0.240 |
Why?
|
| Anesthetics, Dissociative | 1 | 2005 | 18 | 0.230 |
Why?
|
| Stem Cells | 1 | 2010 | 678 | 0.230 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1018 | 0.230 |
Why?
|
| von Willebrand Factor | 2 | 2019 | 183 | 0.220 |
Why?
|
| Orthopedic Surgeons | 1 | 2024 | 13 | 0.210 |
Why?
|
| Radiologists | 1 | 2024 | 47 | 0.210 |
Why?
|
| Humeral Fractures | 1 | 2024 | 26 | 0.210 |
Why?
|
| Strontium | 3 | 2018 | 4 | 0.210 |
Why?
|
| Observer Variation | 1 | 2024 | 302 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2383 | 0.200 |
Why?
|
| Phenotype | 3 | 2021 | 4295 | 0.190 |
Why?
|
| Absorbable Implants | 4 | 2018 | 24 | 0.190 |
Why?
|
| Elastomers | 1 | 2022 | 4 | 0.190 |
Why?
|
| Cell Death | 2 | 2020 | 232 | 0.180 |
Why?
|
| Ketamine | 1 | 2005 | 222 | 0.180 |
Why?
|
| Financial Management | 1 | 2021 | 13 | 0.170 |
Why?
|
| Durapatite | 1 | 2020 | 12 | 0.170 |
Why?
|
| Chemical Phenomena | 1 | 2020 | 81 | 0.170 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2020 | 88 | 0.160 |
Why?
|
| Macromolecular Substances | 1 | 2020 | 141 | 0.160 |
Why?
|
| Spectrum Analysis | 1 | 2020 | 62 | 0.160 |
Why?
|
| Mice | 4 | 2025 | 17528 | 0.160 |
Why?
|
| Nanocomposites | 1 | 2019 | 7 | 0.160 |
Why?
|
| Tensile Strength | 1 | 2019 | 44 | 0.160 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 16 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2023 | 345 | 0.160 |
Why?
|
| Polyesters | 1 | 2019 | 34 | 0.160 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 93 | 0.160 |
Why?
|
| Research Personnel | 1 | 2021 | 124 | 0.160 |
Why?
|
| Nucleotides | 1 | 2019 | 90 | 0.160 |
Why?
|
| Citric Acid | 1 | 2019 | 40 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1132 | 0.150 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 14 | 0.150 |
Why?
|
| Male | 8 | 2024 | 61966 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 150 | 0.140 |
Why?
|
| Asthma | 1 | 2005 | 761 | 0.140 |
Why?
|
| Female | 8 | 2024 | 67790 | 0.140 |
Why?
|
| Arteries | 1 | 2018 | 196 | 0.140 |
Why?
|
| Cell Movement | 1 | 2020 | 842 | 0.130 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1996 | 20 | 0.130 |
Why?
|
| Inflammation | 2 | 2014 | 1428 | 0.120 |
Why?
|
| Osteogenesis | 1 | 2017 | 162 | 0.120 |
Why?
|
| Bioreactors | 1 | 2016 | 43 | 0.120 |
Why?
|
| Sus scrofa | 1 | 2016 | 115 | 0.120 |
Why?
|
| Tibia | 1 | 2015 | 79 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 149 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 528 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 188 | 0.110 |
Why?
|
| Scandium | 1 | 2014 | 1 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 333 | 0.110 |
Why?
|
| Yttrium | 1 | 2014 | 5 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 1996 | 223 | 0.110 |
Why?
|
| Gadolinium | 1 | 2014 | 107 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 348 | 0.100 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 98 | 0.100 |
Why?
|
| Polytetrafluoroethylene | 1 | 2012 | 62 | 0.090 |
Why?
|
| Triage | 1 | 2013 | 143 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 1534 | 0.090 |
Why?
|
| Spirometry | 1 | 2011 | 72 | 0.090 |
Why?
|
| Heparin | 1 | 2012 | 203 | 0.090 |
Why?
|
| Hospitalization | 2 | 2013 | 1804 | 0.090 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2010 | 22 | 0.080 |
Why?
|
| Cadherins | 1 | 2010 | 174 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2010 | 412 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2024 | 16725 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2010 | 754 | 0.070 |
Why?
|
| Adolescent | 4 | 2024 | 19904 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1599 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2002 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3436 | 0.060 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 77 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 237 | 0.060 |
Why?
|
| Texas | 1 | 2013 | 3531 | 0.050 |
Why?
|
| Bronchodilator Agents | 1 | 2005 | 147 | 0.050 |
Why?
|
| Incidence | 1 | 2011 | 3182 | 0.050 |
Why?
|
| Pediatric Emergency Medicine | 1 | 2024 | 46 | 0.050 |
Why?
|
| Emergency Medicine | 1 | 2005 | 155 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2015 | 4446 | 0.050 |
Why?
|
| Thermodynamics | 2 | 2014 | 140 | 0.050 |
Why?
|
| Photoelectron Spectroscopy | 2 | 2012 | 8 | 0.050 |
Why?
|
| Child | 3 | 2024 | 25015 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 418 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2011 | 4878 | 0.050 |
Why?
|
| Prognosis | 1 | 2011 | 4668 | 0.050 |
Why?
|
| Radiography | 1 | 2024 | 745 | 0.050 |
Why?
|
| Calcium | 2 | 2017 | 1019 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1587 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 130 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2013 | 8362 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 14316 | 0.040 |
Why?
|
| Risk Factors | 1 | 2013 | 10346 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2856 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1996 | 4 | 0.030 |
Why?
|
| Adult | 3 | 2012 | 30189 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 1996 | 46 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 5079 | 0.030 |
Why?
|
| Bone Nails | 1 | 2015 | 26 | 0.030 |
Why?
|
| Hydrogen | 1 | 2015 | 42 | 0.030 |
Why?
|
| Pediatrics | 1 | 2005 | 1205 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 92 | 0.030 |
Why?
|
| Corrosion | 1 | 2014 | 2 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2012 | 29 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2012 | 39 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2012 | 103 | 0.020 |
Why?
|
| Cell Shape | 1 | 2012 | 68 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 297 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2012 | 312 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2005 | 12334 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3388 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2012 | 461 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 12758 | 0.020 |
Why?
|
| Thrombosis | 1 | 2012 | 494 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11141 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 7391 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6020 | 0.010 |
Why?
|